UNLIMITED TURBO LONG - AMBU Stock

Certificat

DE000PD7A3G0

Delayed Deutsche Boerse AG 07:20:56 2024-05-29 am EDT
0.96 EUR -3.03% Intraday chart for UNLIMITED TURBO LONG - AMBU
Current month+30.26%
1 month+33.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 0.96 -3.03%
24-05-28 0.99 +1.02%
24-05-27 0.98 -1.01%
24-05-24 0.99 +1.02%
24-05-23 0.98 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 29, 2024 at 07:20 am EDT

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying AMBU A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD7A3G
ISINDE000PD7A3G0
Date issued 2022-06-15
Strike 57.17 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.07
Lowest since issue 0.17
Spread 0.01
Spread %1.03%

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Sector
-
More about the company

Ratings for Ambu A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Ambu A/S

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
129 DKK
Average target price
111.2 DKK
Spread / Average Target
-13.83%
Consensus